Sun Phar­ma tem­porar­i­ly halts ship­ments from man­u­fac­tur­ing plant af­ter FDA let­ter

Sun Phar­ma is paus­ing pro­duc­tion at one of its plants in In­dia af­ter fac­ing scruti­ny by US reg­u­la­tors over nec­es­sary cor­rec­tive work.

In a let­ter to the Na­tion­al Stock Ex­change of In­dia dat­ed Sun­day, Sun Phar­ma said it had been hand­ed a let­ter from the FDA ti­tled, “Con­sent De­cree Cor­re­spon­dence/Non-Com­pli­ance Let­ter.” US reg­u­la­tors con­veyed to Sun Phar­ma that it needs to take cor­rec­tive ac­tions at the man­u­fac­tur­ing fa­cil­i­ty in the city of Mo­hali, In­dia, in the Pun­jab re­gion, be­fore Sun can ship any prod­ucts to the US.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER